Abstract
The clinical use of epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) in the treatment of non-small cell lung cancer was limited......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
